Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ARM's Istitutional Interest has been

ARM's Istitutional Interest has been

posted on Sep 29, 2006 04:36PM
jumping ship last Q . nstitutional Selling Test Compares last quarter's institutional investor shares purchased and sold. Test fails if institutions sold more shares than they bought. Results for ARMHY.O: FAIL Number of Shares Shares Purchased Prev Qtr 4.3 mil Shares Sold Prev Qtr 9.8 mil Net Purchased (5.5) mil Institutional investors have sold more shares of this company than they have purchased. This may indicate Institutional buyers are losing confidence in this stock What will next Q bring ? hopefully A cry from large stock holders to settle quickly. ;)
Share
New Message
Please login to post a reply